#135: SV almost goes B(ust) 📉
The one-minute healthtech roundup.
This week: SV goes B(ust), how to crack America, and why 2023 will either be amazing for healthtech or the worst thing since unsliced bread.
News Bites 🥪
💸 SVB fuelled high-risk, high-reward tech firms. Now health start-ups feel bereft - 12% of SVBs deposits were in healthtech and life sciences. What’s next for our sector?
🏈 How UK healthtechs can get a head start on their US expansion - Valued at $88B this year, the US healthtech market is incredibly attractive to international companies. But what’s the secret to cracking the American nut?
🔎 Why investors should pay close attention to the UK’s healthtech sector in 2023 - The strapline “The UK is becoming the Silicon Valley of Europe's healthcare sector” feels like bad timing, but otherwise an insightful piece from Investment Monitor.
🐄 Culling the health tech herd - Oop, Pigeon’s pulled out the ol’ reverse Uno card. Where Investment Monitor sees opportunity, Politico predicts doom with a light smattering of gloom.
📈 Why do so many biotechs face being kicked off the Nasdaq? - Biotech IPO’s have always been fairly unique, in that firms can often get listed without an MVP. In a sort-of-post-SVB world, how viable is this?
🧑⚖️ MHRA to receive £10m from HM Treasury to fast-track patient access to cutting-edge medical products - MHRA will receive £10 million to help bring innovative new medicines and medical technologies to UK patients more quickly.
👑 Hera crowned Pitchfest start-up winner - Love of pedantry means that Pigeon needs to point out that the award can’t be worn as a crown. Love for Hera’s mission means that Pigeon needs to point out that Hera’s sector is massively under-invested, and that they’re more than worthy winners in a competition littered with excellent startups.
What to listen to 🔊
🐦 SV almost goes B(ust) - Join Jess, James, Belle and Albion VC’s Molly Gilmartin as they take a scalpel to this week’s healthtech news.
🔊 #295 Health information and content creation with YouTube's Head of UK Health Dr Vishaal Virani - This week James talks to Dr Vishaal Virani, Head of Health, UK at YouTube. Vishaal started his diverse career as an NHS doctor, before beginning his journey outside of clinical practice in healthcare strategy consulting.
💥 The implosion of SVB, New York Times - Not sure if we’ve mentioned it yet, but Silicon Valley Bank had a bit of a wobble this week. The NYT’s summary is the best we’ve listened to.
🤑 Finance Director, Phlo - If you’re into cash-phlo, and supporting the CEO, in Glasgow, give this a go. Obviously only give it a go if you’re qualified. Never apply for a role based on the rhyme scheme of the job posting. #lifehack
🐢 Clinician OSLER testing - Tortus are haring* ahead in the AI interface game, and they’re looking for London-based clinicians to try their AI and give them feedback.
*Yes, that is an Aesop's Fables reference in a healthtech newsletter ostensibly written by winged vermin. We’re going high-brow, folks. Keep up.